Last updated on December 2019

TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Myocardial Infarction
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • 18 years old
  • Admitted for STEMI or NSTEMI and invasive management (i.e. coronary angiography during index hospitalization).
  • LVEF>40% as evaluated by any imaging technique anytime during hospitalization.
  • Signed informed consent

Exclusion Criteria:

  • Known allergy or intolerance to beta-blockers
  • Absolute contraindication to beta-blocker therapy according to treating physician judge
  • Prior history of HF, Killip class on admission or during hospitalization II
  • Severe valvular heart disease (> 3+ for aortic or mitral insufficiency, aortic or mitral valve area 1.0 cm2).
  • Any condition (appart from AMI) that requires beta-blocker prescription on discharge according to treating physician judge
  • Any medical condition that, in the investigators judgment, would seriously limit life expectancy (less than one year),
  • Patients participating in other clinical trials

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.